Abstract
Biomimetic nanoparticles enhanced multiple myeloma treatment by removing chemokine (C-C motif) ligand 3 and synergizing PD-L1 blockade
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have